Cough Hypersensitivity Syndrome Treatment Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cough Hypersensitivity Syndrome Treatment Market Analysis
The cough hypersensitivity syndrome treatment market is expected to register a CAGR of 5.5% over the forecast period. The market is projected to register moderate growth over the forecast period, which can be attributed to factors, such as humid climate, unhealthy lifestyle, and rising incidence of diseases.
Cough is a common disease affecting millions of people worldwide. The rise in the prevalence of chronic respiratory diseases globally is leading to an increase in chronic cough conditions globally. Thus, the growing burden of disease offers a promising future for the global market. Although some studies suggest that the risk of developing cough may be increased, due to other certain factors, such as asthma, smoking, hot and humid climate, and viral or bacterial infection.
As per the WHO, cough is ranked as the most prevalent disease globally. Most of the novel products are reformulated drugs with improvised vehicles or combinatorial therapies. The treatment algorithm is witnessing a paradigm shift from small molecules towards natural therapies and biologics. Combination therapies have also been gaining popularity over the last few years. Most industry-sponsored products are in clinical trials.
In addition, the key players are focusing on making cough syrup of pleasant taste and easy intake for oral use. The growing disease burden includes majority of pediatric population as they have lower immunity level compared to adults. Most pediatric patients prefer liquid as dosage forms. Growing demand of cough remedies is driven by the presence of routinely monitored formulations, technological advancement in the field of drug delivery systems, and increasing awareness amongst patients. However, drug abuse and dependence on cough hypersensitivity syndrome drugs are the factors that are expected to restrict the market's growth.
Cough Hypersensitivity Syndrome Treatment Market Trends
This section covers the major market trends shaping the Cough Hypersensitivity Syndrome Treatment Market according to our research experts:
The Retail Pharmacy From Distribution Channel Segment Dominates the Market and is Expected to Continue the Same during the Forecast Period
- The retail pharmacy segment dominated the market, owing to due to easy availability and accessibility of these pharmacies. For instance, MedPlus has around 1650 outlets out of which 1,350 are self-owned and rest are taken as a franchisee. Retailers provide discounts on bulk purchases, offer quick delivery, and always have sufficient product stock, owing to which consumers opt for these distribution channels.
- Moreover, online pharmacy is estimated to be the fastest-growing segment over the forecast period. The convenience of delivering the medicines at the doorstep is the major advantage of online pharmacy. The discounted price that the online pharmacies provide is also a factor that drives the growth of the market. As per an estimate, there are between 30,000 and 50,000 online pharmacies operating in the United States, making online pharmacies a leading segment.
The North America Dominates the Market and is Expected to Continue the Same during the Forecast Period
North America holds the highest share, owing to the presence of major market players. Several collaborative efforts were undertaken by major companies to enhance their R&D capabilities and ensure high medical standards are anticipated to impel the demand across this region. Moreover, the majority share can also be attributed to the high disease burden in this region. Increasing cases of cough and rising pediatric population are the key factors that are driving the market studied in this region.
The Asia-Pacific region is expected to witness the fastest growth over the forecast period. Strategic partnerships between pharmaceutical companies and government organizations are on a rise in the region, particularly to develop generic drugs and spread awareness amongst healthcare professionals. Increasing awareness levels and rising focus of healthcare providers on the eradication of coughing ailments are expected to boost growth within the region. This factor is expected to boost the growth of the APAC market.
Cough Hypersensitivity Syndrome Treatment Industry Overview
The market for cough hypersensitivity syndrome treatment is highly competitive and consists of several global as well as local players. Investment for the development of effective and long-acting products with lesser adverse effects and improving geographic penetration through partnerships and collaborations are the key strategies adopted by the companies to increase their market share. The major players include Johnson & Johnson, Bayer AG, GlaxoSmithKline plc, Pfizer, Novartis, AstraZeneca, and Teva Canada Limited.
Cough Hypersensitivity Syndrome Treatment Market Leaders
-
Johnson & Johnson
-
Bayer AG
-
Teva Canada Limited.
-
GlaxoSmithKline plc
-
Pfizer
*Disclaimer: Major Players sorted in no particular order
Cough Hypersensitivity Syndrome Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Expanding Target Audience
- 4.2.2 Robust Pipeline and the Introduction of Novel Therapies
- 4.2.3 Increasing Government Initiatives
-
4.3 Market Restraints
- 4.3.1 Drug Abuse and Dependency
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Drug Class
- 5.1.1 Antitussive Agents
- 5.1.2 Inhaled Corticosteroids (ICS)
- 5.1.3 Short Acting Beta2-Agonists (SABA)
- 5.1.4 Anti-cholinergics
- 5.1.5 Antihistamines
- 5.1.6 Proton Pump Inhibitors
- 5.1.7 Other Drug Classes
-
5.2 By End User
- 5.2.1 Hospital Pharmacies
- 5.2.2 Retail Pharmacies
- 5.2.3 Online Pharmacies
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle-East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Astrazeneca PLC
- 6.1.2 Bayer AG
- 6.1.3 Boehringer Ingelheim GmbH
- 6.1.4 GlaxoSmithKline PLC
- 6.1.5 Johnson & Johnson Inc.
- 6.1.6 Merck & Co. Inc.
- 6.1.7 Novartis International AG
- 6.1.8 Pfizer Inc.
- 6.1.9 Teva Canada Limited
- 6.1.10 Vertex Pharmaceuticals Incorporated
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Cough Hypersensitivity Syndrome Treatment Industry Segmentation
This report forecasts the growth in revenue at the global, regional, and country levels. It provides an analysis of the latest trends and opportunities in each of the sub-segments from 2017 to 2025. For the purpose of this study, Mordor Intelligence has segmented the global hypersensitivity syndrome treatment market report on the basis of drug class and distribution channel and region.
| By Drug Class | Antitussive Agents | |
| Inhaled Corticosteroids (ICS) | ||
| Short Acting Beta2-Agonists (SABA) | ||
| Anti-cholinergics | ||
| Antihistamines | ||
| Proton Pump Inhibitors | ||
| Other Drug Classes | ||
| By End User | Hospital Pharmacies | |
| Retail Pharmacies | ||
| Online Pharmacies | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Cough Hypersensitivity Syndrome Treatment Market Research FAQs
What is the current Cough Hypersensitivity Syndrome Treatment Market size?
The Cough Hypersensitivity Syndrome Treatment Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)
Who are the key players in Cough Hypersensitivity Syndrome Treatment Market?
Johnson & Johnson, Bayer AG, Teva Canada Limited., GlaxoSmithKline plc and Pfizer are the major companies operating in the Cough Hypersensitivity Syndrome Treatment Market.
Which is the fastest growing region in Cough Hypersensitivity Syndrome Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Cough Hypersensitivity Syndrome Treatment Market?
In 2024, the North America accounts for the largest market share in Cough Hypersensitivity Syndrome Treatment Market.
What years does this Cough Hypersensitivity Syndrome Treatment Market cover?
The report covers the Cough Hypersensitivity Syndrome Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Cough Hypersensitivity Syndrome Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Cough Hypersensitivity Syndrome Treatment Industry Report
Statistics for the 2024 Cough Hypersensitivity Syndrome Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cough Hypersensitivity Syndrome Treatment analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
